Investment Portfolio      
CELLECTRICON AB
Cellectricon provides advanced chip-based technologies within the area of functional cell-based assays, primarily for the discovery of new drugs. The company has an extensive and solid patent portfolio in areas such as high-throughput electrophysiology, patch-clamp, microfluidics, microfabrication, and electroporation. Cellectricon is associated with Chalmers MC2 - a world-class microfabrication facility at Chalmers University of Technology in Gothenburg, Sweden

www.cellectricon.se